Cancer Treatment Effects for Breast Cancer and Lymphoma

This trial aims to understand how cancer treatments affect sexual and reproductive health in women with breast cancer and lymphoma. Participants will answer surveys about their sexual health and may choose to have blood draws and transvaginal ultrasounds to assess fertility. Women recently diagnosed with breast cancer or lymphoma, who are starting treatment soon, and who have either had a period or been pregnant in the last year, might be suitable candidates. This study is open to both premenopausal and postmenopausal women. As an unphased trial, it offers participants the opportunity to contribute to important research that could improve future care for women facing similar health challenges.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Researchers are excited about this trial because it aims to shed light on the sexual and reproductive health of women with breast cancer and lymphoma, areas that are often overlooked in standard care. Unlike typical treatments that focus primarily on cancer eradication, this observational study dives into understanding sexual dysfunction and distress, which are significant quality of life issues for many women. By using detailed surveys and medical assessments like blood draws and transvaginal ultrasounds, the trial seeks to identify the prevalence, severity, and predictors of these issues, potentially guiding future interventions to improve overall patient well-being.